Model: shivamsharma1967/bge-base-financial-matryoshka
Author: shivamsharma1967
Pipeline: sentence-similarity
Library: sentence-transformers
Tags: sentence-transformers, safetensors, bert, sentence-similarity, feature-extraction, generated_from_trainer, dataset_size:135, loss:MatryoshkaLoss, loss:MultipleNegativesRankingLoss, en, arxiv:1908.10084, arxiv:2205.13147, arxiv:1705.00652, base_model:BAAI/bge-base-en-v1.5, base_model:finetune:BAAI/bge-base-en-v1.5, license:apache-2.0, model-index, text-embeddings-inference, endpoints_compatible, region:us
Base models (finetune): id: BAAI/bge-base-en-v1.5
Card metadata: language: en
license: apache-2.0
tags: sentence-transformers, sentence-similarity, feature-extraction, generated_from_trainer, dataset_size:135, loss:MatryoshkaLoss, loss:MultipleNegativesRankingLoss
base_model: BAAI/bge-base-en-v1.5
widget: source_sentence: Worldwide Sales Change 
By Business Segment
Organic sales
Acquisitions
Divestitures
Translation
Total sales change
Safety and Industrial
1.0 %
 
 %
 %
(4.2) %
(3.2) %
Transportation and Electronics
1.2 
 
(0.5)
(4.6)
(3.9)
Health Care
3.2 
 
(1.4)
(3.8)
(2.0)
Consumer
(0.9)
 
(0.4)
(2.6)
(3.9)
Total Company
1.2 
 
(0.5)
(3.9)
(3.2)
Table of Contents
Sales and operating income (loss) by business segment:
The following tables contain sales and operating income (loss) results by business segment for the years ended December 31, 2022 and 2021. Refer to the section entitled
Performance by Business Segment later in MD&A for additional discussion concerning 2022 versus 2021 results, including Corporate and Unallocated. Refer to Note 19 for
additional information on business segments.
2022
2021
% change
(Dollars in millions)
Net Sales
% of Total
Operating
Income (Loss)
Net Sales
% of Total
Operating
Income (Loss)
Net Sales
Operating Income
(Loss)
Business Segments
Safety and Industrial
$
11,604
33.9 % $
1,199 $
11,981
33.9 % $
2,466
(3.2)%
(51.4)%
Transportation and Electronics
8,902
26.0 
1,012
9,262
26.2 
1,880
(3.9)
(46.2)
Health Care
8,421
24.6 
1,815
8,597
24.3 
2,037
(2.0)
(10.9)
Consumer
5,298
15.5 
994
5,513
15.6 
1,162
(3.9)
(14.4)
Corporate and Unallocated
4
 
1,519
2
 
(176)
Total Company
$
34,229 
100.0 % $
6,539 $
35,355 
100.0 % $
7,369 
(3.2)%
(11.3)%
Year ended December 31, 2022
Worldwide Sales Change 
By Business Segment
Organic sales
Acquisitions
Divestitures
Translation
Total sales change
Safety and Industrial
1.0 %
 
 %
 %
(4.2) %
(3.2) %
Transportation and Electronics
1.2 
 
(0.5)
(4.6)
(3.9)
Health Care
3.2 
 
(1.4)
(3.8)
(2.0)
Consumer
(0.9)
 
(0.4)
(2.6)
(3.9)
Total Company
1.2 
 
(0.5)
(3.9)
(3.2)
Sales by geographic area:
Percent change information compares the years ended December 31, 2022 and 2021 with the same prior year period, unless otherwise indicated. Additional discussion of
business segment results is provided in the Performance by Business Segment section.
Year ended December 31, 2022
Americas
Asia Pacific
Europe, Middle East
& Africa
Other Unallocated
Worldwide
Net sales (millions)
$
18,400 
$
9,901 
$
5,928 
$
 
$
34,229 
% of worldwide sales
53.8 %
28.9 %
17.3 %
100.0 %
Components of net sales change:
Organic sales
2.6 
0.3 
(0.6)
1.2 
Divestitures
(0.6)
(0.4)
(0.6)
(0.5)
Translation
(0.3)
(6.5)
(9.8)
(3.9)
Total sales change
1.7 %
(6.6) %
(11.0) %
(3.2) %
Year ended December 31, 2021
Americas
Asia Pacific
Europe, Middle East
& Africa
Other Unallocated
Worldwide
Net sales (millions)
$
18,097 
$
10,600 
$
6,660 
$
(2)
$
35,355 
% of worldwide sales
51.2 %
30.0 %
18.8 %
100.0 %
Components of net sales change:
Organic sales
9.8 
8.5 
6.3 
8.8 
Divestitures
(0.6)
 
(1.1)
(0.5)
Translation
0.3 
2.3 
3.8 
1.6 
Total sales change
9.5 %
10.8 %
9.0 %
9.9 %
25
sentences: Has Pepsico reported any materially important ongoing legal battles from FY2022 and FY2021?, We need to calculate a financial metric by using information only provided within the balance sheet. Please answer the following question: what is Boeing's year end FY2018 net property, plant, and equipment (in USD millions)?, If we exclude the impact of M&A, which segment has dragged down 3M's overall growth in 2022?, source_sentence: dited) 
 
Three months ended 
 
Twelve months ended 
 
December 31, 
2022 
 
December 31, 
2021 
 
December 31, 
2022 
 
December 31, 
2021 
Las Vegas Strip Resorts 
$ 
877,052 $ 
698,739 $ 
3,142,308 $ 
1,738,211 
Regional Operations 
 
319,517 
309,250 
1,294,630 
1,217,814 
MGM China 
 
(54,979) 
5,015 
(203,136) 
25,367 
Unconsolidated affiliates(1) 
 
(43,029) 
(49,698) 
(222,079) 
(131,590) 
Management and other operations 
 
(3,037) 
2,087 
 
(11,934) 
15,766 
Stock compensation 
 
(25,159) 
(26,494) 
(71,297) 
(63,984) 
Corporate(2) 
 
(113,058) 
(117,491) 
(431,238) 
(380,501) 
 
$ 
957,307 
 $ 
3,497,254
Page 13 of 15 
 
 
MGM RESORTS INTERNATIONAL AND SUBSIDIARIES 
SUPPLEMENTAL DATA NET REVENUES 
(In thousands) 
(Unaudited) 
 
Three months ended 
 
Twelve months ended 
 
December 31, 
2022 
 
December 31, 
2021 
 
December 31, 
2022 
 
December 31, 
2021 
Las Vegas Strip Resorts 
$ 
2,297,282 $ 
1,806,686 $ 
8,398,372 $ 
4,737,185 
Regional Operations 
 
991,452 
899,607 
3,815,885 
3,392,363 
MGM China 
 
174,720 
314,717 
673,593 
1,210,761 
Management and other operations 
 
128,762 
35,882 
239,635 
339,831 
 
$ 
3,592,216 $ 
3,056,892 $ 
13,127,485 $ 
9,680,140 
 
 
 
 
 
MGM RESORTS INTERNATIONAL AND SUBSIDIARIES 
SUPPLEMENTAL DATA ADJUSTED PROPERTY EBITDAR AND ADJUSTED EBITDAR 
(In thousands) 
(Unaudited) 
 
Three months ended 
 
Twelve months ended 
 
December 31, 
2022 
 
December 31, 
2021 
 
December 31, 
2022 
 
December 31, 
2021 
Las Vegas Strip Resorts 
$ 
877,052 $ 
698,739 $ 
3,142,308 $ 
1,738,211 
Regional Operations 
 
319,517 
309,250 
1,294,630 
1,217,814 
MGM China 
 
(54,979) 
5,015 
(203,136) 
25,367 
Unconsolidated affiliates(1) 
 
(43,029) 
(49,698) 
(222,079) 
(131,590) 
Management and other operations 
 
(3,037) 
2,087 
 
(11,934) 
15,766 
Stock compensation 
 
(25,159) 
(26,494) 
(71,297) 
(63,984) 
Corporate(2) 
 
(113,058) 
(117,491) 
(431,238) 
(380,501) 
 
$ 
957,307 
 $ 
3,497,254 
 
(1) Represents the Company's share of operating income (loss) excluding investments in real estate ventures, adjusted for the effect of certain basis 
differences. Includes the Company's share of operating results of CityCenter through September 26, 2021 during the twelve months ended December 31, 
2021. 
(2) Three months ended December 31, 2022 includes amounts related to MGM China of $5 million, global development of $6 million, and transaction costs of 
$2 million. Twelve months ended December 31, 2022 includes amounts related to MGM China of $18 million, global development of $20 million, and 
transaction costs of $42 million. Three months ended December 31, 2021 includes amounts related to MGM China of $4 million, global development of $10 
million, and transaction costs of $8 million. Twelve months ended December 31, 2021 includes amounts related to MGM China of $16 million, global 
development of $23 million, and transaction costs of $34 million.
sentences: Which region had the Highest EBITDAR Contribution for MGM during FY2022?, How much has the effective tax rate of American Express changed between FY2021 and FY2022?, Which region had the worst topline performance for MGM during FY2022?, source_sentence: Amcor plc and Subsidiaries
Consolidated Balance Sheet
(in millions)
As of June 30,
2020
2019
Assets
Current assets:
Cash and cash equivalents
$
742.6 
$
601.6 
Trade receivables, net
1,615.9 
1,864.3 
Inventories, net
1,831.9 
1,953.8 
Prepaid expenses and other current assets
344.3 
374.3 
Assets held for sale
 
416.1 
Total current assets
4,534.7 
5,210.1 
Non-current assets:
Investments in affiliated companies
77.7 
98.9 
Property, plant and equipment, net
3,614.8 
3,975.0 
Operating lease assets
525.3 
 
Deferred tax assets
135.4 
190.9 
Other intangible assets, net
1,994.3 
2,306.8 
Goodwill
5,339.3 
5,156.0 
Employee benefit assets
43.4 
40.2 
Other non-current assets
177.2 
187.1 
Total non-current assets
11,907.4 
11,954.9 
Total assets
$
16,442.1 
$
17,165.0 
Liabilities
Current liabilities:
Current portion of long-term debt
$
11.1 
$
5.4 
Short-term debt
195.2 
788.8 
Trade payables
2,170.8 
2,303.4 
Accrued employee costs
476.5 
378.4 
Other current liabilities
1,120.0 
1,044.9 
Liabilities held for sale
 
20.9 
Total current liabilities
3,973.6 
4,541.8 
Non-current liabilities:
Long-term debt, less current portion
6,028.4 
5,309.0 
Operating lease liabilities
465.7 
 
Deferred tax liabilities
672.4 
1,011.7 
Employee benefit obligations
391.7 
386.8 
Other non-current liabilities
223.2 
241.0 
Total non-current liabilities
7,781.4 
6,948.5 
Total liabilities
11,755.0 
11,490.3 
Commitments and contingencies (See Note 19)
Shareholders' Equity
Amcor plc shareholders equity:
Ordinary shares ($0.01 par value):
Authorized (9,000.0 shares)
Issued (1,568.5 and 1,625.9 shares, respectively)
15.7 
16.3 
Additional paid-in capital
5,480.0 
6,007.5 
Retained earnings
246.5 
323.7 
Accumulated other comprehensive income (loss)
(1,049.3)
(722.4)
Treasury shares (6.7 and 1.4 shares, respectively)
(67.0)
(16.1)
Total Amcor plc shareholders' equity
4,625.9 
5,609.0 
Non-controlling interest
61.2 
65.7 
Total shareholders' equity
4,687.1 
5,674.7 
Total liabilities and shareholders' equity
$
16,442.1 
$
17,165.0 
See accompanying notes to consolidated financial statements.
50
Amcor plc and Subsidiaries
Consolidated Balance Sheet
(in millions)
As of June 30,
2020
2019
Assets
Current assets:
Cash and cash equivalents
$
742.6 
$
601.6 
Trade receivables, net
1,615.9 
1,864.3 
Inventories, net
1,831.9 
1,953.8 
Prepaid expenses and other current assets
344.3 
374.3 
Assets held for sale
 
416.1 
Total current assets
4,534.7 
5,210.1 
Non-current assets:
Investments in affiliated companies
77.7 
98.9 
Property, plant and equipment, net
3,614.8 
3,975.0 
Operating lease assets
525.3 
 
Deferred tax assets
135.4 
190.9 
Other intangible assets, net
1,994.3 
2,306.8 
Goodwill
5,339.3 
5,156.0 
Employee benefit assets
43.4 
40.2 
Other non-current assets
177.2 
187.1 
Total non-current assets
11,907.4 
11,954.9 
Total assets
$
16,442.1 
$
17,165.0 
Liabilities
Current liabilities:
Current portion of long-term debt
$
11.1 
$
5.4 
Short-term debt
195.2 
788.8 
Trade payables
2,170.8 
2,303.4 
Accrued employee costs
476.5 
378.4 
Other current liabilities
1,120.0 
1,044.9 
Liabilities held for sale
 
20.9 
Total current liabilities
3,973.6 
4,541.8 
Non-current liabilities:
Long-term debt, less current portion
6,028.4 
5,309.0 
Operating lease liabilities
465.7 
 
Deferred tax liabilities
672.4 
1,011.7 
Employee benefit obligations
391.7 
386.8 
Other non-current liabilities
223.2 
241.0 
Total non-current liabilities
7,781.4 
6,948.5 
Total liabilities
11,755.0 
11,490.3 
Commitments and contingencies (See Note 19)
Shareholders' Equity
Amcor plc shareholders equity:
Ordinary shares ($0.01 par value):
Authorized (9,000.0 shares)
Issued (1,568.5 and 1,625.9 shares, respectively)
15.7 
16.3 
Additional paid-in capital
5,480.0 
6,007.5 
Retained earnings
246.5 
323.7 
Accumulated other comprehensive income (loss)
(1,049.3)
(722.4)
Treasury shares (6.7 and 1.4 shares, respectively)
(67.0)
(16.1)
Total Amcor plc shareholders' equity
4,625.9 
5,609.0 
Non-controlling interest
61.2 
65.7 
Total shareholders' equity
4,687.1 
5,674.7 
Total liabilities and shareholders' equity
$
16,442.1 
$
17,165.0 
See accompanying notes to consolidated financial statements.
50
sentences: What is Amcor's year end FY2020 net AR (in USD millions)? Address the question by adopting the perspective of a financial analyst who can only use the details shown within the balance sheet., Is Boeing's business subject to cyclicality?, Does AMD have a reasonably healthy liquidity profile based on its quick ratio for FY22? If the quick ratio is not relevant to measure liquidity, please state that and explain why., source_sentence: Exhibit 99.1
Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue
Separation

Company expects increased 2023 Reported Sales Growth of 7.0% - 8.0%, Operational Sales Growth of 7.5% - 8.5%, and
Adjusted Operational Sales Growth of 6.2% - 7.2%; Figures exclude the COVID-19 Vaccine

Company expects 2023 Adjusted Reported Earnings Per Share (EPS) of $10.00 - $10.10, reflecting increased growth of
12.5% at the mid-point and Adjusted Operational EPS of $9.90 - $10.00, reflecting increased growth of 11.5% at the mid-
point

Company reduced outstanding share count by approximately 191 million; 2023 guidance reflects only a partial-year benefit
of approximately 73.5 million shares or $0.28 benefit to EPS

Company secured $13.2 billion in cash proceeds from the Kenvue debt offering and initial public offering and maintains 9.5%
of equity stake in Kenvue

Company maintains its quarterly dividend of $1.19 per share
New Brunswick, N.J. (August 30, 2023) Johnson & Johnson (NYSE: JNJ) (the Company) today announced updates to its financials and
2023 guidance which reflect its operations as a company focused on transformational innovation in Pharmaceutical and MedTech. The
Company has published a recorded webinar for investors to provide additional context behind the updated financials and 2023 guidance
found in this release, which may be accessed by visiting the Investors section of the Company's website at webcasts & presentations.
The completion of this transaction uniquely positions Johnson & Johnson as a Pharmaceutical and MedTech company focused on delivering
transformative healthcare solutions to patients, said Joaquin Duato, Chairman of the Board and Chief Executive Officer. We are incredibly
proud of the focus and dedication of our employees worldwide to achieve this milestone, which we are confident will unlock near- and long-
term value for all of our stakeholders.
As previously announced, the Company recently completed an exchange offer to finalize the separation of Kenvue Inc., formerly Johnson &
Johnsons Consumer Health business. As a result of the completion of the exchange offer, Johnson & Johnson will now present its
Consumer Health business financial results as discontinued operations, including a gain of approximately $20 billion in the third quarter of
2023
Exhibit 99.1
Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue
Separation

Company expects increased 2023 Reported Sales Growth of 7.0% - 8.0%, Operational Sales Growth of 7.5% - 8.5%, and
Adjusted Operational Sales Growth of 6.2% - 7.2%; Figures exclude the COVID-19 Vaccine

Company expects 2023 Adjusted Reported Earnings Per Share (EPS) of $10.00 - $10.10, reflecting increased growth of
12.5% at the mid-point and Adjusted Operational EPS of $9.90 - $10.00, reflecting increased growth of 11.5% at the mid-
point

Company reduced outstanding share count by approximately 191 million; 2023 guidance reflects only a partial-year benefit
of approximately 73.5 million shares or $0.28 benefit to EPS

Company secured $13.2 billion in cash proceeds from the Kenvue debt offering and initial public offering and maintains 9.5%
of equity stake in Kenvue

Company maintains its quarterly dividend of $1.19 per share
New Brunswick, N.J. (August 30, 2023) Johnson & Johnson (NYSE: JNJ) (the Company) today announced updates to its financials and
2023 guidance which reflect its operations as a company focused on transformational innovation in Pharmaceutical and MedTech. The
Company has published a recorded webinar for investors to provide additional context behind the updated financials and 2023 guidance
found in this release, which may be accessed by visiting the Investors section of the Company's website at webcasts & presentations.
The completion of this transaction uniquely positions Johnson & Johnson as a Pharmaceutical and MedTech company focused on delivering
transformative healthcare solutions to patients, said Joaquin Duato, Chairman of the Board and Chief Executive Officer. We are incredibly
proud of the focus and dedication of our employees worldwide to achieve this milestone, which we are confident will unlock near- and long-
term value for all of our stakeholders.
As previously announced, the Company recently completed an exchange offer to finalize the separation of Kenvue Inc., formerly Johnson &
Johnsons Consumer Health business. As a result of the completion of the exchange offer, Johnson & Johnson will now present its
Consumer Health business financial results as discontinued operations, including a gain of approximately $20 billion in the third quarter of
2023.
sentences: What is the quantity of restructuring costs directly outlined in Pepsico's income statements for FY2022? If restructuring costs are not explicitly outlined then state 0., Were there any board member nominees who had substantially more votes against joining than the other nominees?, Which business segment of JnJ will be treated as a discontinued operation from August 30, 2023 onward?, source_sentence: Table of Contents
AMAZON.COM, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in millions, except per share data)
 
 
Year Ended December 31,
 
2015
 
2016
 
2017
Net product sales
$
79,268 $
94,665 $
118,573
Net service sales
27,738 
41,322 
59,293
Total net sales
107,006 
135,987 
177,866
Operating expenses:
 
 
 
Cost of sales
71,651 
88,265 
111,934
Fulfillment
13,410 
17,619 
25,249
Marketing
5,254 
7,233 
10,069
Technology and content
12,540 
16,085 
22,620
General and administrative
1,747 
2,432 
3,674
Other operating expense, net
171 
167 
214
Total operating expenses
104,773 
131,801 
173,760
Operating income
2,233 
4,186 
4,106
Interest income
50 
100 
202
Interest expense
(459) 
(484) 
(848)
Other income (expense), net
(256) 
90 
346
Total non-operating income (expense)
(665) 
(294) 
(300)
Income before income taxes
1,568 
3,892 
3,806
Provision for income taxes
(950) 
(1,425) 
(769)
Equity-method investment activity, net of tax
(22) 
(96) 
(4)
Net income
$
596 $
2,371 $
3,033
Basic earnings per share
$
1.28 $
5.01 $
6.32
Diluted earnings per share
$
1.25 $
4.90 $
6.15
Weighted-average shares used in computation of earnings per share:
 
 
 
Basic
467 
474 
480
Diluted
477 
484 
493
See accompanying notes to consolidated financial statements.
38
Table of Contents
AMAZON.COM, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in millions, except per share data)
 
 
Year Ended December 31,
 
2015
 
2016
 
2017
Net product sales
$
79,268 $
94,665 $
118,573
Net service sales
27,738 
41,322 
59,293
Total net sales
107,006 
135,987 
177,866
Operating expenses:
 
 
 
Cost of sales
71,651 
88,265 
111,934
Fulfillment
13,410 
17,619 
25,249
Marketing
5,254 
7,233 
10,069
Technology and content
12,540 
16,085 
22,620
General and administrative
1,747 
2,432 
3,674
Other operating expense, net
171 
167 
214
Total operating expenses
104,773 
131,801 
173,760
Operating income
2,233 
4,186 
4,106
Interest income
50 
100 
202
Interest expense
(459) 
(484) 
(848)
Other income (expense), net
(256) 
90 
346
Total non-operating income (expense)
(665) 
(294) 
(300)
Income before income taxes
1,568 
3,892 
3,806
Provision for income taxes
(950) 
(1,425) 
(769)
Equity-method investment activity, net of tax
(22) 
(96) 
(4)
Net income
$
596 $
2,371 $
3,033
Basic earnings per share
$
1.28 $
5.01 $
6.32
Diluted earnings per share
$
1.25 $
4.90 $
6.15
Weighted-average shares used in computation of earnings per share:
 
 
 
Basic
467 
474 
480
Diluted
477 
484 
493
See accompanying notes to consolidated financial statements.
38
sentences: We want to calculate a financial metric. Please help us compute it by basing your answers off of the statement of income and the statement of cash flows. Here's the question: what is the FY2015 unadjusted EBITDA % margin for Netflix? Calculate unadjusted EBITDA using unadjusted operating income and D&A (from cash flow statement)., What is Amazon's year-over-year change in revenue from FY2016 to FY2017 (in units of percents and round to one decimal place)? Calculate what was asked by utilizing the line items clearly shown in the statement of income., What is the FY2018 - FY2020 3 year average of capex as a % of revenue for MGM Resorts? Answer in units of percents and round to one decimal place. Please utilize information provided primarily within the statement of cash flows and the statement of income.
pipeline_tag: sentence-similarity
library_name: sentence-transformers
metrics: cosine_accuracy@1, cosine_accuracy@3, cosine_accuracy@5, cosine_accuracy@10, cosine_precision@1, cosine_precision@3, cosine_precision@5, cosine_precision@10, cosine_recall@1, cosine_recall@3, cosine_recall@5, cosine_recall@10, cosine_ndcg@10, cosine_mrr@10, cosine_map@100
model-index: name: BGE base Financial Matryoshka
results: task: type: information-retrieval
name: Information Retrieval
dataset: name: dim 768
type: dim_768
metrics: type: cosine_accuracy@1
value: 0.4
name: Cosine Accuracy@1
verified: no, type: cosine_accuracy@3
value: 0.4666666666666667
name: Cosine Accuracy@3
verified: no, type: cosine_accuracy@5
value: 0.5333333333333333
name: Cosine Accuracy@5
verified: no, type: cosine_accuracy@10
value: 0.6666666666666666
name: Cosine Accuracy@10
verified: no, type: cosine_precision@1
value: 0.4
name: Cosine Precision@1
verified: no, type: cosine_precision@3
value: 0.15555555555555553
name: Cosine Precision@3
verified: no, type: cosine_precision@5
value: 0.10666666666666667
name: Cosine Precision@5
verified: no, type: cosine_precision@10
value: 0.06666666666666667
name: Cosine Precision@10
verified: no, type: cosine_recall@1
value: 0.4
name: Cosine Recall@1
verified: no, type: cosine_recall@3
value: 0.4666666666666667
name: Cosine Recall@3
verified: no, type: cosine_recall@5
value: 0.5333333333333333
name: Cosine Recall@5
verified: no, type: cosine_recall@10
value: 0.6666666666666666
name: Cosine Recall@10
verified: no, type: cosine_ndcg@10
value: 0.502939332667103
name: Cosine Ndcg@10
verified: no, type: cosine_mrr@10
value: 0.4540740740740741
name: Cosine Mrr@10
verified: no, type: cosine_map@100
value: 0.46697870822531695
name: Cosine Map@100
verified: no, task: type: information-retrieval
name: Information Retrieval
dataset: name: dim 512
type: dim_512
metrics: type: cosine_accuracy@1
value: 0.26666666666666666
name: Cosine Accuracy@1
verified: no, type: cosine_accuracy@3
value: 0.4666666666666667
name: Cosine Accuracy@3
verified: no, type: cosine_accuracy@5
value: 0.5333333333333333
name: Cosine Accuracy@5
verified: no, type: cosine_accuracy@10
value: 0.6666666666666666
name: Cosine Accuracy@10
verified: no, type: cosine_precision@1
value: 0.26666666666666666
name: Cosine Precision@1
verified: no, type: cosine_precision@3
value: 0.15555555555555553
name: Cosine Precision@3
verified: no, type: cosine_precision@5
value: 0.10666666666666667
name: Cosine Precision@5
verified: no, type: cosine_precision@10
value: 0.06666666666666667
name: Cosine Precision@10
verified: no, type: cosine_recall@1
value: 0.26666666666666666
name: Cosine Recall@1
verified: no, type: cosine_recall@3
value: 0.4666666666666667
name: Cosine Recall@3
verified: no, type: cosine_recall@5
value: 0.5333333333333333
name: Cosine Recall@5
verified: no, type: cosine_recall@10
value: 0.6666666666666666
name: Cosine Recall@10
verified: no, type: cosine_ndcg@10
value: 0.45372996647663066
name: Cosine Ndcg@10
verified: no, type: cosine_mrr@10
value: 0.38740740740740737
name: Cosine Mrr@10
verified: no, type: cosine_map@100
value: 0.40238523659576286
name: Cosine Map@100
verified: no, task: type: information-retrieval
name: Information Retrieval
dataset: name: dim 256
type: dim_256
metrics: type: cosine_accuracy@1
value: 0.2
name: Cosine Accuracy@1
verified: no, type: cosine_accuracy@3
value: 0.4
name: Cosine Accuracy@3
verified: no, type: cosine_accuracy@5
value: 0.4
name: Cosine Accuracy@5
verified: no, type: cosine_accuracy@10
value: 0.6
name: Cosine Accuracy@10
verified: no, type: cosine_precision@1
value: 0.2
name: Cosine Precision@1
verified: no, type: cosine_precision@3
value: 0.13333333333333333
name: Cosine Precision@3
verified: no, type: cosine_precision@5
value: 0.08
name: Cosine Precision@5
verified: no, type: cosine_precision@10
value: 0.060000000000000005
name: Cosine Precision@10
verified: no, type: cosine_recall@1
value: 0.2
name: Cosine Recall@1
verified: no, type: cosine_recall@3
value: 0.4
name: Cosine Recall@3
verified: no, type: cosine_recall@5
value: 0.4
name: Cosine Recall@5
verified: no, type: cosine_recall@10
value: 0.6
name: Cosine Recall@10
verified: no, type: cosine_ndcg@10
value: 0.37396900668871336
name: Cosine Ndcg@10
verified: no, type: cosine_mrr@10
value: 0.3050793650793651
name: Cosine Mrr@10
verified: no, type: cosine_map@100
value: 0.3252781685635812
name: Cosine Map@100
verified: no, task: type: information-retrieval
name: Information Retrieval
dataset: name: dim 128
type: dim_128
metrics: type: cosine_accuracy@1
value: 0.2
name: Cosine Accuracy@1
verified: no, type: cosine_accuracy@3
value: 0.3333333333333333
name: Cosine Accuracy@3
verified: no, type: cosine_accuracy@5
value: 0.4
name: Cosine Accuracy@5
verified: no, type: cosine_accuracy@10
value: 0.5333333333333333
name: Cosine Accuracy@10
verified: no, type: cosine_precision@1
value: 0.2
name: Cosine Precision@1
verified: no, type: cosine_precision@3
value: 0.1111111111111111
name: Cosine Precision@3
verified: no, type: cosine_precision@5
value: 0.08
name: Cosine Precision@5
verified: no, type: cosine_precision@10
value: 0.05333333333333333
name: Cosine Precision@10
verified: no, type: cosine_recall@1
value: 0.2
name: Cosine Recall@1
verified: no, type: cosine_recall@3
value: 0.3333333333333333
name: Cosine Recall@3
verified: no, type: cosine_recall@5
value: 0.4
name: Cosine Recall@5
verified: no, type: cosine_recall@10
value: 0.5333333333333333
name: Cosine Recall@10
verified: no, type: cosine_ndcg@10
value: 0.34596364164665
name: Cosine Ndcg@10
verified: no, type: cosine_mrr@10
value: 0.28833333333333333
name: Cosine Mrr@10
verified: no, type: cosine_map@100
value: 0.3060450128033935
name: Cosine Map@100
verified: no, task: type: information-retrieval
name: Information Retrieval
dataset: name: dim 64
type: dim_64
metrics: type: cosine_accuracy@1
value: 0.26666666666666666
name: Cosine Accuracy@1
verified: no, type: cosine_accuracy@3
value: 0.26666666666666666
name: Cosine Accuracy@3
verified: no, type: cosine_accuracy@5
value: 0.3333333333333333
name: Cosine Accuracy@5
verified: no, type: cosine_accuracy@10
value: 0.4666666666666667
name: Cosine Accuracy@10
verified: no, type: cosine_precision@1
value: 0.26666666666666666
name: Cosine Precision@1
verified: no, type: cosine_precision@3
value: 0.08888888888888888
name: Cosine Precision@3
verified: no, type: cosine_precision@5
value: 0.06666666666666667
name: Cosine Precision@5
verified: no, type: cosine_precision@10
value: 0.04666666666666666
name: Cosine Precision@10
verified: no, type: cosine_recall@1
value: 0.26666666666666666
name: Cosine Recall@1
verified: no, type: cosine_recall@3
value: 0.26666666666666666
name: Cosine Recall@3
verified: no, type: cosine_recall@5
value: 0.3333333333333333
name: Cosine Recall@5
verified: no, type: cosine_recall@10
value: 0.4666666666666667
name: Cosine Recall@10
verified: no, type: cosine_ndcg@10
value: 0.3413478052343165
name: Cosine Ndcg@10
verified: no, type: cosine_mrr@10
value: 0.30396825396825394
name: Cosine Mrr@10
verified: no, type: cosine_map@100
value: 0.3220458144190396
name: Cosine Map@100
verified: no
Likes: 0 | All-time downloads: 51
Created: 2025-03-11 09:22:21